FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950779966> ?p ?o ?g. }

• W2950779966 endingPage "1351" @default.
• W2950779966 startingPage "1342" @default.
• W2950779966 abstract "Paclitaxel drug-coated balloons and drug-eluting stents became commercially available for the treatment of intermittent claudication in 2015 and 2012, respectively. Both devices demonstrated superiority in limb revascularization compared with non–paclitaxel-coated devices and were rapidly accepted into clinical practice. In a recent systematic review and study-level meta-analysis, Katsanos et al reported a late all-cause mortality signal for patients in the drug-coated balloon and drug-eluting stent arms of randomized clinical trials for both devices. As a result of this safety signal, Vascular InterVentional Advances Physicians (VIVA), a not-for-profit 501c(3) organization, convened the Vascular Leaders Forum on March 1 and 2, 2019, in Washington, DC, to initiate an open and collaborative process of investigation into this finding. The Vascular Leaders Forum brought together 100 stakeholders, including an international group of representatives of cardiovascular medicine, interventional radiology, vascular medicine, and vascular surgery; oncologists; basic scientists; the Food and Drug Administration; the Centers for Medicare and Medicaid Services; and commercial manufacturers of these products. The Vascular Leaders Forum reviewed the natural history of peripheral arterial disease, the use of paclitaxel in peripheral arterial disease and other conditions, the harm signal noted by Katsanos et al, the impact of the methods chosen by Katsanos et al, possible mechanisms of harm, the role of the Food and Drug Administration in a setting like this one, and guidance for clinicians taking care of patients with symptomatic peripheral arterial disease. This document integrates the most current data to help establish an appropriate path forward to understand the risks and benefits associated with these technologies while ensuring the best treatment paradigm for patients." @default.
• W2950779966 created "2019-06-27" @default.
• W2950779966 creator A5001309351 @default.
• W2950779966 creator A5087523470 @default.
• W2950779966 date "2019-10-15" @default.
• W2950779966 modified "2023-10-14" @default.
• W2950779966 title "Paclitaxel-Coated Balloons and Eluting Stents: Is There a Mortality Risk in Patients With Peripheral Artery Disease?" @default.
• W2950779966 cites W188696429 @default.
• W2950779966 cites W1926340908 @default.
• W2950779966 cites W1973003340 @default.
• W2950779966 cites W1975980370 @default.
• W2950779966 cites W1979084017 @default.
• W2950779966 cites W1997684599 @default.
• W2950779966 cites W1999359428 @default.
• W2950779966 cites W2033890227 @default.
• W2950779966 cites W2034774374 @default.
• W2950779966 cites W2040816046 @default.
• W2950779966 cites W2049120615 @default.
• W2950779966 cites W2079135140 @default.
• W2950779966 cites W2091205535 @default.
• W2950779966 cites W2099986164 @default.
• W2950779966 cites W2114011251 @default.
• W2950779966 cites W2122891093 @default.
• W2950779966 cites W2123302216 @default.
• W2950779966 cites W2123528875 @default.
• W2950779966 cites W2134430160 @default.
• W2950779966 cites W2135820925 @default.
• W2950779966 cites W2140776350 @default.
• W2950779966 cites W2141165366 @default.
• W2950779966 cites W2143967622 @default.
• W2950779966 cites W2148666746 @default.
• W2950779966 cites W2152647863 @default.
• W2950779966 cites W2154054522 @default.
• W2950779966 cites W2162172759 @default.
• W2950779966 cites W2164175810 @default.
• W2950779966 cites W2170931151 @default.
• W2950779966 cites W2295508527 @default.
• W2950779966 cites W2347152092 @default.
• W2950779966 cites W2430015321 @default.
• W2950779966 cites W2766460973 @default.
• W2950779966 cites W2768470007 @default.
• W2950779966 cites W2789737428 @default.
• W2950779966 cites W2793477810 @default.
• W2950779966 cites W2903350476 @default.
• W2950779966 cites W2904940887 @default.
• W2950779966 cites W2913667111 @default.
• W2950779966 cites W2918814647 @default.
• W2950779966 cites W2946328497 @default.
• W2950779966 cites W78097482 @default.
• W2950779966 doi "https://doi.org/10.1161/circulationaha.119.041099" @default.
• W2950779966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31177820" @default.
• W2950779966 hasPublicationYear "2019" @default.
• W2950779966 type Work @default.
• W2950779966 sameAs 2950779966 @default.
• W2950779966 citedByCount "41" @default.
• W2950779966 countsByYear W29507799662019 @default.
• W2950779966 countsByYear W29507799662020 @default.
• W2950779966 countsByYear W29507799662021 @default.
• W2950779966 countsByYear W29507799662022 @default.
• W2950779966 countsByYear W29507799662023 @default.
• W2950779966 crossrefType "journal-article" @default.
• W2950779966 hasAuthorship W2950779966A5001309351 @default.
• W2950779966 hasAuthorship W2950779966A5087523470 @default.
• W2950779966 hasBestOaLocation W29507799661 @default.
• W2950779966 hasConcept C126322002 @default.
• W2950779966 hasConcept C141071460 @default.
• W2950779966 hasConcept C160735492 @default.
• W2950779966 hasConcept C162324750 @default.
• W2950779966 hasConcept C168563851 @default.
• W2950779966 hasConcept C177713679 @default.
• W2950779966 hasConcept C2776534028 @default.
• W2950779966 hasConcept C2777466421 @default.
• W2950779966 hasConcept C2779134260 @default.
• W2950779966 hasConcept C2779464278 @default.
• W2950779966 hasConcept C3018348675 @default.
• W2950779966 hasConcept C3018890749 @default.
• W2950779966 hasConcept C500558357 @default.
• W2950779966 hasConcept C50522688 @default.
• W2950779966 hasConcept C535046627 @default.
• W2950779966 hasConcept C545542383 @default.
• W2950779966 hasConcept C71924100 @default.
• W2950779966 hasConceptScore W2950779966C126322002 @default.
• W2950779966 hasConceptScore W2950779966C141071460 @default.
• W2950779966 hasConceptScore W2950779966C160735492 @default.
• W2950779966 hasConceptScore W2950779966C162324750 @default.
• W2950779966 hasConceptScore W2950779966C168563851 @default.
• W2950779966 hasConceptScore W2950779966C177713679 @default.
• W2950779966 hasConceptScore W2950779966C2776534028 @default.
• W2950779966 hasConceptScore W2950779966C2777466421 @default.
• W2950779966 hasConceptScore W2950779966C2779134260 @default.
• W2950779966 hasConceptScore W2950779966C2779464278 @default.
• W2950779966 hasConceptScore W2950779966C3018348675 @default.
• W2950779966 hasConceptScore W2950779966C3018890749 @default.
• W2950779966 hasConceptScore W2950779966C500558357 @default.
• W2950779966 hasConceptScore W2950779966C50522688 @default.
• W2950779966 hasConceptScore W2950779966C535046627 @default.
• W2950779966 hasConceptScore W2950779966C545542383 @default.
• W2950779966 hasConceptScore W2950779966C71924100 @default.

• next